Prediction: 3 Stocks That Will Be Worth More Than Palantir 5 Years From Now

The article argues Palantir is materially overvalued after its stock rose nearly 800% since early 2024 while Q1 revenue grew 39% year over year; it trades at 113x sales and 244x forward earnings. Even assuming 40% annual revenue growth for five years, a 30% profit margin and no additional dilution, Palantir would generate an estimated $5 billion in 2030 profit and still trade at roughly 67x those hypothetical earnings. The author favors ASML, IBM and Salesforce as cheaper AI-related alternatives, citing ASML's EUV-chip-equipment leadership, IBM's AI and quantum-computing pivot, and Salesforce's AI-enabled CRM opportunity.

Analysis

This is not a new fundamental catalyst; it is a valuation-discipline reminder in a momentum-sensitive AI complex. The key market mechanism is that PLTR’s multiple leaves little room for merely good execution: any deceleration in commercial bookings, net-dollar retention, or operating-margin expansion can trigger a sharp de-rating even if revenue remains healthy. Conversely, the stock’s retail participation and AI-theme ownership make a naked short vulnerable to squeezes around contract announcements and earnings.

A cleaner relative-value expression is to fund PLTR exposure with companies where AI monetization is tied to either installed-base upsell (CRM), enterprise infrastructure spend (IBM), or semiconductor-capex intensity (ASML). These are not interchangeable substitutes: CRM needs paid Agentforce adoption rather than free feature attachment; IBM needs consulting and software backlog conversion; ASML depends on foundry utilization, customer capex plans, and export-control outcomes. The article's broad comparison therefore understates ASML's cyclical and China-policy risk while overstating the immediacy of IBM's quantum optionality.

Over the next 1-3 months, the decisive catalysts are PLTR’s commercial growth and forward revenue guide versus consensus, plus evidence that incremental AI demand is converting into durable multi-year contracts rather than pilot activity. Over 6-18 months, dilution, customer concentration, and the pace of margin expansion determine whether PLTR can grow into its valuation. The contrarian case is that PLTR's ontology and deployment model create unusually sticky production workloads; if commercial growth reaccelerates while share-based-compensation dilution moderates, relative-value shorts can fail despite an optically demanding multiple.

Given the low-news-impact nature of the source, avoid treating this as a standalone directional catalyst. The actionable setup is conditional on refreshed valuation, short-interest, options-skew, and consensus-estimate data; without those, the better posture is a monitored relative-value thesis rather than an immediate large short.

Key Decisions for Investors

• Watch for a PLTR short / CRM long dollar-neutral pair after the next PLTR earnings print if PLTR guides commercial revenue below consensus while CRM maintains subscription-growth and operating-margin guidance. Target a 15-25% relative return over 3-6 months; exit if PLTR raises full-year revenue expectations materially or CRM shows AI-related pricing pressure.
• For defined-risk downside, consider PLTR put spreads 3-6 months out only if implied volatility is below its pre-earnings percentile range. Structure strikes around a 15-25% downside window rather than buying far out-of-the-money puts; the thesis is multiple compression, not insolvency. Do not initiate if options skew already prices a large post-earnings decline.
• Maintain ASML as a separate 12-18 month AI-capex exposure rather than using it as a pure PLTR hedge. Add only after confirming 2026 order visibility and customer capex guidance; reduce on evidence of incremental export restrictions or delayed leading-edge fab ramps.
• Treat IBM as watchlist optionality, not a primary AI winner. Upgrade only if software growth, bookings/backlog conversion, and consulting attach rates demonstrate monetization; falsify the thesis if AI announcements do not translate into recurring revenue acceleration over the next two reporting periods.
• Set a PLTR risk alert around the next earnings release: a combination of sustained commercial growth acceleration, upward revenue guidance, and lower dilution would invalidate the bearish valuation thesis and warrants covering relative-value shorts promptly.